Inventors
Yin Shan Eric Ng, Gopalan Gnanaguru, Ashley Mackey, Patricia A D'amore
Publication date
2021/6/3
Patent office
US
Application number
17171528
Description
The invention provides a solution to the clinical problem of retinal pigment epithelium (RPE) degeneration or geo graphic atrophy (GA) associated AMD. PPARy selective agonists, eg, troglitazone and analogs thereof are used to reduce or inhibit RPE degeneration, GA, and/or the pro gression of dry AMD.
Scholar articles
YSE Ng, G Gnanaguru, A Mackey, PA D'amore - US Patent App. 17/171,528, 2021